Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**EPCIP antisense RNA 1 (EPCIP-AS1)** is a long non-coding RNA gene located on human chromosome 21 (position 32,772,100–33,019,751) [4]. It does not code for a protein [5]. As an antisense RNA, EPCIP-AS1 is classified among lncRNAs that overlap and are transcribed in the opposite direction of a protein-coding gene; in this case, the EPCIP gene, which codes for exosomal polycystin-1-interacting protein [1][5][6]. The specific biological roles of EPCIP-AS1 itself have not been characterized, and there is limited evidence directly connecting this RNA to a role in disease, target, or biomarker utility [5]. Antisense lncRNAs like EPCIP-AS1 typically regulate the expression of their sense (protein-coding) gene partners or nearby genes via various mechanisms, including modulation of transcription, RNA stability, and chromatin state [2][3][5][6]. These functions generally affect gene regulation rather than serving as traditional "drug targets" (such as receptors, enzymes, or transporters). Accordingly, there are no known drugs, mechanisms of drug action, or established biomarker or safety data specific to EPCIP-AS1. In summary, **EPCIP-AS1** is best described as a non-protein-coding, long antisense RNA, with its function presumed to be related to the regulation of gene expression through antisense RNA mechanisms, but it is not a recognized therapeutic target, and there is currently insufficient evidence for its direct disease association or use in therapy [2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EPCIP antisense RNA 1 (EPCIP-AS1).